Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Treasury Shares (2019 - 2026)

Viatris (VTRS) posted Treasury Shares of $1.2 billion for Q2 2026, up 14.89% on a QoQ basis from $1.0 billion in Q1 2026, and up 35.21% year-over-year from $855.8 million in Q2 2025.

Analysis

Viatris (VTRS) Treasury Shares (2019 - 2026) Analysis & Trends

Viatris has reported Treasury Shares for 2 years, with the latest figure at $24.6 million in Q1 2020.

  • On a quarterly basis, Treasury Shares rose 35.21% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 35.21% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 99.72% from the prior year.
  • Treasury Shares was $1.2 billion for Q2 2026 at Viatris, up from $1.0 billion in the prior quarter.
  • The five-year high for Treasury Shares was $1.2 billion in Q2 2026, with the low at $251.8 million in Q1 2023.
  • Average Treasury Shares over 4 years is $618.3 million, with a median of $504.3 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Treasury Shares jumped 100.28% in 2024, then jumped 34.8% in 2025.
  • Over 4 years, Treasury Shares stood at $251.8 million in 2023, then surged by 100.28% to $504.3 million in 2024, then soared by 99.72% to $1.0 billion in 2025, then increased by 14.88% to $1.2 billion in 2026.
  • The last three Treasury Shares figures came in at $1.2 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 106.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 1.16 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -16.50 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 891,915.00
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -19.77 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Bn
Jun 30, 2026 1.16 Bn
Mar 31, 2026 1.01 Bn
Mar 31, 2026 1.01 Bn
Dec 31, 2025 1.01 Bn
Dec 31, 2025 1.01 Bn
Sep 30, 2025 924.20 Mn
Sep 30, 2025 924.20 Mn
Jun 30, 2025 855.80 Mn
Jun 30, 2025 855.80 Mn
Mar 31, 2025 679.80 Mn
Mar 31, 2025 679.80 Mn
Dec 31, 2024 504.30 Mn
Dec 31, 2024 504.30 Mn
Sep 30, 2024 504.30 Mn
Sep 30, 2024 504.30 Mn
Jun 30, 2024 504.30 Mn
Jun 30, 2024 504.30 Mn
Mar 31, 2024 504.30 Mn
Mar 31, 2024 504.30 Mn